The category of Vmn2r17 Inhibitors comprises a diverse array of chemical compounds that, while not directly targeting Vmn2r17, possess the ability to indirectly modulate the signaling pathways and cellular processes that underlie the function of Vmn2r17. This indirect approach to inhibition reflects a strategic understanding of the complex nature of cellular signaling networks, where modulation of one component can lead to alterations in the activity or expression of target proteins such as Vmn2r17. By influencing key signaling molecules and pathways-ranging from kinases and phosphatases to G-protein coupled receptors (GPCRs) and calcium signaling mechanisms-the selected compounds can indirectly affect the functional context within which Vmn2r17 operates, providing insights into its role in sensory signaling and cellular communication.
This approach emphasizes the interconnectedness of cellular signaling pathways and the potential for chemical intervention to provide insights into the regulatory mechanisms controlling the activity of proteins like Vmn2r17. Through the modulation of signaling pathways that Vmn2r17 is either directly or indirectly involved in, these compounds serve as valuable tools for exploring the biological functions of Vmn2r17 and the complex regulatory networks that govern cellular signaling. This methodology underscores the utility of indirect modulation as a strategy for investigating the roles of specific receptors within the vast network of cellular communication, facilitating a deeper understanding of the signaling processes that drive cellular function and behavior. Through such exploration, the inhibitors not only enhance our comprehension of Vmn2r17's biological roles but also illustrate the broader principles of signal transduction and the potential of chemical compounds to dissect the intricate signaling networks that underpin cellular life.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor affecting multiple signaling pathways that could indirectly modulate Vmn2r17's activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Tyrosine kinase inhibitor, potentially affecting signaling mechanisms indirectly related to Vmn2r17 function. | ||||||
NF449 | 627034-85-9 | sc-478179 sc-478179A sc-478179B | 10 mg 25 mg 100 mg | $203.00 $469.00 $1509.00 | 1 | |
Gsα subunit-specific antagonist, could impact GPCR-mediated signaling pathways relevant to Vmn2r17. | ||||||
KT 5720 | 108068-98-0 | sc-3538 sc-3538A sc-3538B | 50 µg 100 µg 500 µg | $138.00 $220.00 $972.00 | 47 | |
PKA inhibitor, potentially altering cAMP-mediated signaling processes that may influence Vmn2r17 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor, affecting AKT signaling pathways that could be relevant to Vmn2r17's signaling context. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor, could impact MAPK/ERK signaling pathways indirectly related to Vmn2r17 function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor, potentially modulating stress response signaling pathways associated with Vmn2r17. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor, could affect apoptosis and inflammation signaling pathways relevant to Vmn2r17's function. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
Calmodulin inhibitor, potentially affecting calcium signaling pathways indirectly related to Vmn2r17 activity. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
Inhibits CaMKII, potentially influencing calcium-dependent signaling pathways relevant to Vmn2r17. | ||||||